26 March 2010  .  Chakra Biotech Sdn Bhd Completes Series B Investment Round
	Chakra Biotech Sdn Bhd, a Malaysian based Contract Research Organisation (CRO) has completed a MYR18.2m Series B funding round. This brings total funding for the company to MYR20.0m. Malaysian Life Sciences Capital Fund Ltd (MLSCF) and the Malaysian Technology Development Corporation Sdn Bhd (MTDC) participated in the round. Please click here for the full press release.
	25 September 2009  .  Chakra Biotech Lists on goBalto
	Chakra Biotech Sdn Bhd (http://www.gobalto.com/companies/chakra-biotech) is featured on goBalto under Preclinical and Nonclinical (http://www.gobalto.com/partners/preclinical-and-nonclinical-services) and Animal Models (http://www.gobalto.com/partners/preclinical-animal-models-services). goBalto is the fastest growing online tool for drug development companies to find Partnering solutions worldwide.
	11 March 2009  .  Chakra Biotech Sdn Bhd Celebrates Official Opening
	The opening ceremony was officiated by the Deputy Minister for Science, Technology and Innovation, Y.B Hj. Fadilah Bin Yusof on behalf of the Minister for Science, Technology and Innovation, Y.B. Datuk Dr. Maximus Ongkili. Around 100 guests from the life science community attended the official opening ceremony.
	04 August 2008  .  Dr Anil Ratty, Chief Scientific Architect of Chakra Biotech Sdn Bhd to present at DDT Mumbai India
	Dr Anil Ratty, Chief Scientific Architect of Chakra Biotech Sdn Bhd has been invited to present at the Drug Discovery and Development of Innovative Therapeutics conference to be held from 20 - 22 October 2008 in Mumbai India. The conference is organised by IBC and brings together a full range of global pharma and biotech interested in outsourcing drug discovery and development work to the Asian region. Dr Ratty will present the validation of the chakragati mouse as a model for schizophrenia.
	25 July 2008  .  Chakra Biotech Sdn Bhd Raises Venture Capital
	Malaysian Life Science Capital Fund Ltd (MLSCF) and the Malaysian Technology Development Corporation Sdn Bhd (MTDC) have made an equity investment in Chakra Biotech Sdn Bhd. MLSCF is a joint venture between MTDC and Burrill & Co., USA. This investment will allow Chakra Biotech to fully develop their plans to offer neurobehavioural screening services to the global pharma and biotech industry.
	01 April 2008  .  Chakra Biotech Sdn Bhd commences operations at USAINS in Penang, Malaysia
	Chakra Biotech Sdn Bhd today announced that it had commenced operations at the USAINS Eureka Kompleks in Penang Malaysia. "Our plans are to build a world class neurobehavioural lab to help our customers screen new and existing drugs. In this way we can help them to discover new medicines for psychiatric and other CNS disorders" said Anthony Bishop a Director of the company who has been appointed as the CEO.
	15 February 2008  .  Chakra Biotech Sdn Bhd awarded Biotechnology Commercialisation Grant by Malaysian Biotechnology Corporation
	Chakra Biotech Sdn Bhd has been awarded a Biotechnology Commercialisation Grant by the Malaysian Biotechnology Corporation. The grant enables companies to set up operations and begin to develop international markets.
	23 July 2007  .  Chakra Biotech Sdn Bhd awarded Bionexus status by Malaysian Biotechnology Corporation
	Chakra Biotech Sdn Bhd has been awarded Bionexus status by Malaysian Biotechnology Corporation. BioNexus Status is a designation awarded to qualifying biotechnology companies, making them eligible for privileges contained within the BioNexus Bill of Guarantees. "We appreciate the award of Bionexus Status to Chakra Biotech Sdn Bhd and the invaluable assistance in many ways from Biotech Corp in setting up our company" said Anthony Bishop, Director of Chakra Biotech Sdn Bhd.